articles Ratings /ratings/en/research/articles/250320-u-s-states-brace-for-potential-medicaid-funding-gaps-13447206 content esgSubNav
In This List
COMMENTS

U.S. States Brace For Potential Medicaid Funding Gaps

COMMENTS

History Of U.S. State Ratings

COMMENTS

U.S. State Ratings And Outlooks: Current List

COMMENTS

Swirling Economic Winds Keep Mineral-Producing U.S. States On Their Toes

COMMENTS

U.S. Public Finance Credit Ratings Are Typically Resilient To A Federal Government Shutdown


U.S. States Brace For Potential Medicaid Funding Gaps

Federal-Level Changes Could Materially Alter Medicaid Funding And Place A High Burden On States

Uncertainty surrounding the level of federal participation in the Medicaid and CHIP funding partnership could make states' budgets more vulnerable to medical cost increases. Absorbing higher costs could also be more difficult during an economic downturn if revenue trends decline and Medicaid rolls increase. S&P Global Ratings considers Medicaid expenditures to be a nondiscretionary, fixed cost for most states, given that state-level Medicaid changes must remain compliant with all federal requirements, barring a waiver or allowance to modify Medicaid.

Several options that might be considered as part of the budget reconciliation process that could affect Medicaid include:

  • Moving to a fixed block grant program structure;
  • Establishing work requirements for eligibility;
  • Lowering the current 50% floor for certain states' federal medical assistance percentage (FMAP);
  • Reducing the federal reimbursement rate, which varies by state; and
  • Limiting or eliminating states' ability to levy provider taxes.

The move to a fixed block grant could cap federal Medicaid funding to states, with annual adjustments tied only to population growth. This is a departure from the current percentage-based federal-state formula, which is adjusted based on various economic, demographic, enrollment, or health care demands that necessitate funding adjustments. Other options' impacts could be costly, such as establishing work requirements to determine or retain Medicaid eligibility, or lowering the current floor for certain states' FMAP set in statute at 50%. This change could affect 10 higher income states that currently receive funding at this rate, as could lower federal reimbursement of adult Medicaid expansion population to states' normal FMAP formula rate from the current 90%. Another option--to limit or eliminate states' levying of provider taxes--could remove a key Medicaid program funding source used by 49 states.

This shift in funding responsibilities could introduce downside credit risks for states if absorbing higher Medicaid costs strains their financial capacity, or if it is compounded by other structural budget pressures.

Chart 1

image

Table 1

For 35 states, Medicaid and CHIP enrollment exceeds one-fifth of their population
Rank State Medicaid and CHIP enrollment (Oct. 1, 2024) Medicaid and CHIP enrollment (% of state population)
1 New Mexico 764,407 36.2
2 California 13,431,928 34.5
3 Alaska 250,131 34.1
4 New York 6,652,419 34.0
5 Louisana 1,511,871 33.1
6 Oregon 1,300,251 30.7
7 Kentucky 1,385,144 30.6
8 West Virginia 510,971 28.9
9 Hawaii 402,818 28.1
10 Rhode Island 306,344 28.0
11 Arkansas 821,017 26.8
12 Arizona 1,963,200 26.4
13 Indiana 1,804,429 26.3
14 Illinois 3,243,413 25.8
15 Connecticut 932,771 25.8
16 North Carolina 2,776,584 25.6
17 Maine 350,738 25.1
18 Maryland 1,525,201 24.7
19 Ohio 2,875,313 24.4
20 Oklahoma 988,293 24.4
21 Vermont 157,471 24.3
22 Delaware 250,651 24.3
23 Pennsylvania 3,106,529 24.0
24 Nevada 760,981 23.8
25 Massachusetts 1,658,082 23.7
26 Michigan 2,364,114 23.6
27 Washington 1,837,170 23.5
28 Iowa 674,985 21.0
29 Virginia 1,809,526 20.8
30 Mississippi 602,825 20.5
31 Missouri 1,269,477 20.5
32 Minnesota 1,167,743 20.4
33 Colorado 1,185,011 20.2
34 Tennessee 1,436,211 20.2
35 Wisconsin 1,189,424 20.1
36 Montana 218,858 19.3
37 South Carolina 1,037,498 19.3
38 New Jersey 1,753,610 18.9
39 Alabama 952,073 18.6
40 Georgia 1,978,819 17.9
41 Nebraska 341,081 17.2
42 Florida 3,765,231 16.7
43 Idaho 314,819 16.0
44 South Dakota 142,007 15.4
45 Kansas 411,381 14.0
46 Texas 4,178,724 13.7
47 North Dakota 104,911 13.4
48 New Hampshire 183,563 13.1
49 Wyoming 63,292 10.8
50 Utah 339,379 9.9
CHIP--Children’s Health Insurance Program. Source: October 2024 applications, eligibility, and enrollment dataset by state. Sources: Centers for Medicare and Medicaid Services, Medicaid.gov., S&P Global Ratings.

Chart 2

image

Table 2

image

States' Autonomy To Manage Medicaid Programs Could Partly Mitigate Elevated Funding Risks

Barring the emergence of other structural or economic pressures, we view most states as well-positioned to absorb short-term Medicaid spending increases. States' considerable expenditure flexibility and record-high reserves and liquidity amassed over the past three fiscal years could serve as a near-term buffer to manage some spending increases as they weigh long-term funding solutions. States have also demonstrated substantial resilience and increased savings for economic and fiscal uncertainties in the wake of the pandemic. Some, such as Indiana, Ohio, Oklahoma, Tennessee, and Utah have set aside resources through specified Medicaid stabilization or trust funds from accumulated excess savings to further cushion state finances during a potential transitional period in Medicaid funding.

To mitigate ongoing cost pressures, states might implement more drastic actions, including eligibility or benefit restrictions, or cut payments to providers to close Medicaid funding gaps. However, these actions could be partly counterbalanced by other costs associated with a higher uninsured population or cuts that can add financial stress on hospitals and health providers.

Chart 3

image

A Strong Federal-State Medicaid Partnership Remains Critical To State Credit Quality

As it did in past economic downturns and recessions, periods where enrollment and health costs typically increase, the federal government helped close an otherwise substantial Medicaid funding gap during the pandemic, including through nearly $120 billion in emergency funding, automatic stabilizers, and enhanced Medicaid reimbursement rates. Providing this stability and expenditure flexibility for many state budgets aids general state credit conditions in countercyclical periods. A weaker federal response to future Medicaid program needs--whether due to reduced fiscal capacity, structural program and funding changes, or a change in policy--will likely further strain states' fiscal conditions in difficult economic times.

Considering elevated policy uncertainty on Medicaid funding, we'll continue to monitor how states balance health care quality and efficiency with reducing administrative and programmatic costs to curb Medicaid spending. In our opinion, this has made continuous budget monitoring and forecasting critical tools during this transition period.

Related Research

This report does not constitute a rating action.

Primary Credit Analysts:Thomas J Zemetis, New York + 1 (212) 4381172;
thomas.zemetis@spglobal.com
Geoffrey E Buswick, Boston + 1 (617) 530 8311;
geoffrey.buswick@spglobal.com
Secondary Contacts:Ladunni M Okolo, Dallas + 1 (212) 438 1208;
ladunni.okolo@spglobal.com
Oscar Padilla, Dallas + 1 (214) 871 1405;
oscar.padilla@spglobal.com
Sussan S Corson, New York + 1 (212) 438 2014;
sussan.corson@spglobal.com

No content (including ratings, credit-related analyses and data, valuations, model, software, or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced, or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of Standard & Poor’s Financial Services LLC or its affiliates (collectively, S&P). The Content shall not be used for any unlawful or unauthorized purposes. S&P and any third-party providers, as well as their directors, officers, shareholders, employees, or agents (collectively S&P Parties) do not guarantee the accuracy, completeness, timeliness, or availability of the Content. S&P Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an “as is” basis. S&P PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED, OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P’s opinions, analyses, and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment, and experience of the user, its management, employees, advisors, and/or clients when making investment and other business decisions. S&P does not act as a fiduciary or an investment advisor except where registered as such. While S&P has obtained information from sources it believes to be reliable, S&P does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives. Rating-related publications may be published for a variety of reasons that are not necessarily dependent on action by rating committees, including, but not limited to, the publication of a periodic update on a credit rating and related analyses.

To the extent that regulatory authorities allow a rating agency to acknowledge in one jurisdiction a rating issued in another jurisdiction for certain regulatory purposes, S&P reserves the right to assign, withdraw, or suspend such acknowledgement at any time and in its sole discretion. S&P Parties disclaim any duty whatsoever arising out of the assignment, withdrawal, or suspension of an acknowledgment as well as any liability for any damage alleged to have been suffered on account thereof.

S&P keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain business units of S&P may have information that is not available to other S&P business units. S&P has established policies and procedures to maintain the confidentiality of certain nonpublic information received in connection with each analytical process.

S&P may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P reserves the right to disseminate its opinions and analyses. S&P's public ratings and analyses are made available on its Web sites, www.spglobal.com/ratings (free of charge), and www.ratingsdirect.com (subscription), and may be distributed through other means, including via S&P publications and third-party redistributors. Additional information about our ratings fees is available at www.spglobal.com/usratingsfees.